Member Exclusive

Cell therapy weekly: Fujifilm to pump JP¥10 billion into contract manufacturing

This week: DiscGenics spinal cord therapy passes first-in-human safety review and research uncovers why checkpoint blockade therapies succeed or fail.

Go to the profile of RegMedNet
Jan 10, 2019

Please sign in or register for FREE

No comments yet.